Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Otsuka Novel Products GmbH
Sponsor:
Information provided by (Responsible Party):
Otsuka Novel Products GmbH
ClinicalTrials.gov Identifier:
NCT02042885
First received: January 17, 2014
Last updated: July 18, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)